The failed merger with Humana didn’t help matters, but the main culprit in Aetna’s losing money in the first quarter is its Obamacare health plans, Aetna officials said yesterday.

The mortality gap between white and black America still exists, but it’s getting smaller. In fact, black Americans who reach age 65 are now expected to live longer than white Americans of the same age, according to a study by the CDC that looks at death rates for the 21st century.

Hospitals across the United States are trimming jobs amid financial pressures and fears about the direction that Republicans are steering health care policy, according to a report from STAT News. During the past month, hospitals in 10 states––from Kentucky to Minnesota to New Mexico––have announced plans for staff reductions.

The Patient Protection and Affordable Care Act (PPACA) has shown surprising staying power, thanks largely to hospitals, doctors, and other health-industry players putting up strong opposition to the GOP’s health care plans, according to an article in the Seattle Times. Deep-pocketed medical associations are leading the charge, wielding their cons

Money that has helped states with Zika virus tracking and education may come to an end by this summer, putting at risk efforts to better understand the virus and the severe birth defects associated with it, according to a report from Kaiser Health News (KHN).

The FDA has granted accelerated approval to durvalumab (Imfinzi, AstraZeneca/MedImmune) for the treatment of patients with locally advanced or metastatic urothelial carcinoma who experience disease progression during or after platinum-containing chemotherapy, or whose disease has progressed within 12 months after receiving platinum-containing chemotherapy

Researchers in Ireland have developed a bioinspired antimicrobial treatment that can rapidly kill drug-resistant bacteria. The treatment consists of iodo-thiocyanate complexes, which are inspired by enzymes and reactive molecules produced by the human immune system.

CEO J. Mario Molina, and his brother, CFO John Molina were fired by the company’s board of directors. The announcement, made today, cited the company’s disappointing financial performance, according to FierceHealthcare. The Molina brothers are the sons of the company’s founder, C. David Molina.

For years hospitals have been the big man on the health care campus, elbowing health insurers out of the way thanks to a cascade of mergers and acquisitions. Now, they’re downsizing and laying workers off, according to STAT.

Congress has agreed to include a $2 billion funding increase for the National Institutes of Health (NIH) in a proposed spending package aimed at keeping the government financed through the end of September, according to an article posted on the FierceBiotech website.

In an interview on NBC’s “Meet the Press,” Vice President Mike Pence said he hopes Congress can pass legislation to replace the Patient Protection and Affordable Care Act (PPACA) by the end of the year––far longer than President Trump has envisioned, according to a report from Bloomberg Politics.

The FDA has given the green light to abaloparatide subcutaneous injection (Tymlos, Radius Health) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed on or are intolerant of other available osteoporosis therapy.

Brigatinib (Alunbrig, Takeda Pharmaceutical Company) has received accelerated approval from the FDA for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non–small-cell lung cancer (NSCLC) who have progressed on or are intolerant of crizotinib.

Scientists in Poland have developed a new type of wound dressing that uses an antibacterial substance extracted from the shells of crustaceans, such as shrimp. Their research is described in the May issue of Radiation Physics and Chemistry.

After striking a deal with the conservative Freedom Caucus, House GOP leaders appeared hopeful that a vote on their dormant health care bill would occur this week––but no such luck. Now moderates are refusing to approve the plan because it allows states to cut insurance coverage for people with pre-existing conditions.

Pages